|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 37 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$410,220 |
I/I |
32,630 |
1,215,554 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$82,673 |
I/I |
6,576 |
323,576 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$51,658 |
I/I |
4,109 |
282,109 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-04-30 |
4 |
B |
$12.56 |
$3,870,283 |
I/I |
306,022 |
10,552,695 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-04-30 |
4 |
B |
$12.56 |
$106,830 |
I/I |
8,447 |
223,060 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-06 |
4 |
S |
$12.62 |
$3,625,407 |
I/I |
(286,764) |
2,849,035 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-06 |
4 |
S |
$12.62 |
$410,982 |
I/I |
(32,508) |
312,441 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$18,974 |
I/I |
(1,499) |
35,429 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$59,164 |
I/I |
(4,674) |
110,347 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$617,006 |
I/I |
(48,744) |
1,151,014 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$308,642 |
I/I |
(24,383) |
575,768 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-28 |
4 |
B |
$12.70 |
$210,837 |
I/I |
16,579 |
204,151 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$5,881,836 |
I/I |
(463,082) |
2,288,013 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$666,930 |
I/I |
(52,508) |
248,829 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$4,046 |
I/I |
(318) |
35,111 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$12,645 |
I/I |
(994) |
109,353 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$131,810 |
I/I |
(10,361) |
1,140,653 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$65,937 |
I/I |
(5,183) |
570,585 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-30 |
4 |
B |
$12.76 |
$151,919 |
I/I |
11,901 |
241,295 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-30 |
4 |
B |
$12.76 |
$5,079,843 |
I/I |
397,943 |
3,135,799 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-30 |
4/A |
B |
$12.76 |
$575,866 |
I/I |
45,112 |
344,949 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-02 |
4 |
S |
$12.94 |
$397,796 |
I/I |
(30,734) |
956,958 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-02 |
4 |
S |
$12.94 |
$12,231 |
I/I |
(945) |
29,457 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-02 |
4 |
S |
$12.94 |
$38,144 |
I/I |
(2,947) |
91,743 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-02 |
4 |
S |
$12.94 |
$198,989 |
I/I |
(15,374) |
478,696 |
0 |
- |
|
1397 Records found
|
|
Page 37 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|